Cargando…
A Comparative Study of Tumor-Specificity and Neurotoxicity between 3-Styrylchromones and Anti-Cancer Drugs
Background. Many anti-cancer drugs used in clinical practice cause adverse events such as oral mucositis, neurotoxicity, and extravascular leakage. We have reported that two 3-styrylchromone derivatives, 7-methoxy-3-[(1E)-2-phenylethenyl]-4H-1-benzopyran-4-one (Compound A) and 3-[(1E)-2-(4-hydroxyph...
Autores principales: | Abe, Tomoyuki, Sakagami, Hiroshi, Amano, Shigeru, Uota, Shin, Bandow, Kenjiro, Uesawa, Yoshihiro, U, Shiori, Shibata, Hiroki, Takemura, Yuri, Kimura, Yu, Takao, Koichi, Sugita, Yoshiaki, Sato, Akira, Tanuma, Sei-ichi, Takeshima, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10386476/ https://www.ncbi.nlm.nih.gov/pubmed/37505064 http://dx.doi.org/10.3390/medicines10070043 |
Ejemplares similares
-
A Dual Anti-Inflammatory and Anti-Proliferative 3-Styrylchromone Derivative Synergistically Enhances the Anti-Cancer Effects of DNA-Damaging Agents on Colon Cancer Cells by Targeting HMGB1-RAGE-ERK1/2 Signaling
por: Tanuma, Sei-ichi, et al.
Publicado: (2022) -
Effects of 3-styrylchromones on metabolic profiles and cell death in oral squamous cell carcinoma cells
por: Sakagami, Hiroshi, et al.
Publicado: (2015) -
A Unique Anti-Cancer 3-Styrylchromone Suppresses Inflammatory Response via HMGB1-RAGE Signaling
por: Abe, Hideaki, et al.
Publicado: (2021) -
Tumor-Specificity, Neurotoxicity, and Possible Involvement of the Nuclear Receptor Response Pathway of 4,6,8-Trimethyl Azulene Amide Derivatives
por: Naitoh, Kotone, et al.
Publicado: (2022) -
Development of Newly Synthesized Chromone Derivatives with High Tumor Specificity against Human Oral Squamous Cell Carcinoma
por: Sugita, Yoshiaki, et al.
Publicado: (2020)